Search Results - "Krivorot'ko, P V"

The state of cancer care in Russia: breast cancer. Epidemiology and survival of patients. The impact of the SARS-CoV-2-beta-coronavirus epidemic (clinical and population study) by Merabishvili, V. M., Semiglazov, V. F., Komiakhov, A. V., Semiglazova, T. Yu, Krivorotko, P. V., Belyaev, А. M.

“…Background . Breast cancer is the main cause of morbidity and mortality of the female population among economically developed countries, including in Russia…”
Get full text

The impact of adjuvant radiotherapy for cosmetic results after immediate breast reconstruction based on the tissue expander and permanent implant by Bryantseva, Zh. V., Novikov, S. N., Ulrikh, D. G., Krivorotko, P. V., Akulova, I. A., Yaganova, T. S., Tabagua, T. T., Zernov, K. Yu

“…Background. One of the causes of complications in breast cancer patients after immediate breast reconstruction (IBR) is postmastectomy radiation therapy…”
Get full text

Three-dimensional automated breast ultrasound – a supplemental screening tool by Busko, E. A., Semiglazov, V. V., Rozhkova, N. I., Dzhahilova, S. K., Akzyanova, E. R., Krivorotko, P. V., Ryazanov, V. V., Bagnenko, S. S.

“…Background. Three-dimensional automated breast ultrasound (ABUS) is an innovative technology that allows global visualization of the breast and eliminates the…”
Get full text

Current approaches to systemic treatment of BRCA-associated triple-negative breast cancer by Enaldieva, D. A., Krivorotko, P. V., Imyanitov, E. N., Zhiltsova, E. K., Donskikh, R. V., Shaikhelislamova, L. F., Gigolaeva, L. P., Semiglazov, V. F.

“…BRCA -associated triple-negative breast cancer (TNBC) is characterized by high sensitivity to DNA-damaging cytotoxic drugs. The use of well-known BRCA1/2…”
Get full text

The Role of Contrast-Enhanced Imaging Methods in Breast Cancer Early Diagnostics and Treatment Planning by Tyurin, I. Е., Rozhkova, N. I., Artamonova, E. V., Busko, E. A., Didenko, V. V., Zikiryakhodzhaev, A. D., Karpova, M. S., Kvetenadze, G. Е., Krivorot’ko, P. V., Mazo, M. L., Petrovsky, A V., Puchkova, О. S., Serebryakova, S. V., Bakulev, А. P.

“…Оn March 27, 2023, а multidisciplinary Advisory Board meeting was held in Moscow with the participation of Е.V. Artamonova, Е.А. Busko, V.V. Didenko, А.D…”
Get full text

Results of organ-preserving treatment of breast cancer using intraoperative radial therapy by Chumachenko, I. S., Murashko, R. A., Keshabyan, A. A., Krivorotko, P. V., Novikov, S. N.

“…Objective : to compare the immediate and long-term outcomes of patients with early breast cancer treated with intraoperative radial therapy depending on the…”
Get full text

Assessment of resection margins during breast-conserving surgery using multimodal optical coherence tomography by Vorontsov, D. A., Gubarkova, E. V., Sirotkina, M. A., Sovetskiy, A. A., Aleksakhina, S. N., Tabagua, T. T., Busko, E. A., Imyanitov, E. N., Kuznetsov, S. S., Vorontsov, A. Yu, Zagaynova, E. V., Gamayunov, S. V., Zaytsev, V. Yu, Krivorotko, P. V., Gladkova, N. D.

“…Background . Breast cancer (BC) has been ranked first in morbidity and mortality among the female population in Russian Federation for several years. Rapid and…”
Get full text

Utility of dual-energy contrast-enhanced spectral mammography for the diagnosis of multicentric breast cancer by Chyornaya, A. V., Ulyanova, R.  Kh, Krivorotko, P.  V., Artemyeva, A. S., Bagnenko, S. S., Zhiltsova, E. K., Novikov, S. N., Danilov, V. V., Krzhivitskiy, P.  I., Semiglazov, V. F.

“…Background . Breast cancer (BC) can be unifocal, multifocal, multicentric (MCBC) and bilateral according to number and localization of tumors. MCBC has…”
Get full text

Diagnostic capabilities of breast scintigraphy and molecular imaging of the mammary glands in the detection of various biological subtypes of breast cancer by Popova, N.  S., Novikov, S. N. , Krzhivitskiy, P.  I., Zhukova, L. A., Krivorotko, P.  V., Artemyeva, A.  S., Michnin, A. E., Valitova, A. A., Danilov, V. V., Chyornaya, A. V., Tabagua, T. T., Bryantseva, Zh.  V., Akulova, I.  A. , Kanaev, S.  V.

“…Background. The accurate and early diagnosis of breast cancer can improve efficacy of the treatment. The standard diagnostic methods such as mammography,…”
Get full text

The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience by Enaldieva, D. A., Krivorotko, P. V., Imyanitov, E. N., Zhiltsova, E. K., Donskikh, R. V., Sokolenko, A. P., Shaykhelislamova, L. F., Tabagua, T. T., Gigolaeva, L. P., Komyakhov, A. V., Nikolaev, K. S., Zernov, K. Yu, Ereshchenko, S. S., Paltuev, R. M., Bessonov, A. A., Artemyeva, A. S., Pesotskiy, R. S., Amirov, N. S., Emelyanov, A. S., Mortada, V. V., Bondarchuk, Ya. I., Semiglazov, V. V., Semiglazova, T. Yu, Semiglazov, V. F., Belyaev, A. M.

“…   Background.  BRCA-associated triple negative breast cancer (TNBC) is considered one of the most aggressive subtypes of breast cancer with high sensitivity…”
Get full text

Intraoperative evaluation of the resection margin with the usage of digital two-point sectorography (Faxitron PathVision) by Bondarchuk, Ya. I., Zhiltsova, E. K., Krivorotko, P. V., Pesotskiy, R. S., Emelyanov, A. S., Tabagua, T. T., Gigolaeva, L. P., Yereshchenko, S. S., Komyakhov, A. V., Nikolaev, K. S., Zernov, K. Yu, Semiglazov, V. V., Paltuev, R. M., Mortada, V. V., Shaykhelislamova, L. F., Enaldieva, D. A., Amirov, N. S., Channov, V. S., Artemyeva, A. S., Chernaya, A. V., Ulyanova, R. Kh, Semiglazov, V. F.

“…Background . Surgery is fundamental in complex and combined approach in the treatment of the early breast cancer. It is a common fact, that absence of tumor…”
Get full text

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases by Semiglazova, T.  Yu. , Sharashenidze, S.  M. , Kerimova, S.  N. , Klimenko, V.   V., Malygin, A. Yu. , Dashyan, G.  A. , Paltuev, R.   M., Semiglazov, V.  V. , Krivorotko, P.   V., Novikov, S.  N. , Semiglazov, V.   F.

“…The article discusses modern approaches in the treatment of HER2-positive breast cancer (BC) with brain metastases (BM).The patients are subject to…”
Get full text

Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response by Krivorotko, P. V., Mortada, V. V., Pesotskiy, R. S., Artemyeva, A. S., Emelyanov, A. S., Ereshchenko, S. S., Dashyan, G. A., Amirov, N. S., Tabagua, T. T., Gigolaeva, L. P., Komyakhov, A. V., Nikolaev, K. S., Mortada, M. M., Zernov, K. Yu, Zhiltsova, E. K., Smirnova, V. O., Bondarchuk, Ya. I., Enaldieva, D. A., Novikov, S. N., Busko, E. A., Chernaya, A. V., Krzhivitskiy, P. I., Paltuev, R. M., Semiglazova, T. Yu, Semiglazov, V. F., Belyaev, A. M.

“…Background. Achieving a pathologic complete response (pCR) after neoadjuvant systemic therapy (NST) is a predictive factor for improving disease free and…”
Get full text

Comparison of cosmetic results after treatment in women with breast cancer who received additional radiation to the tumor bed by Akulova, I. A., Novikov, S. N., Tseluyko, A. I., Chernaya, A. V., Bryantseva, Zh. V., Krivorotko, P. V., Kanaev, S. V.

“…Objective : to compare cosmetic result of two techniques of boost delivery to the tumor bed after breast concerving treatment. Materials and methods . A…”
Get full text

Post-neoadjuvant treatment of breast cancer by Semiglazov, V. F., Dzhelialova, M. A., Yerechshenko, S. S., Munaeva, E. T., Pesotsky, R. S., Tseluyko, A. I., Emelyanov, A. S., Donskikh, R. V., Krivorotko, P. V.

“…Achieving a pathologic complete response as a result of neoadjuvant treatment is associated with improved prognosis in breast cancer. The CREATE-X trial showed…”
Get full text

Immunology and immunotherapy in the complex treatment of malignant tumors by Semiglazov, V. F., Tseluiko, A. I., Baldueva, I. A., Nekhaeva, T. L., Artemyeva, A. S., Kudaybergenova, A. G., Protsenko, S. A., Novik, A. V., Semiglazov, V. V., Donskikh, R. V., Semiglazova, T. Yu, Pesotskiy, R. S., Apollonova, V. S., Krivorotko, P. V., Belyaev, A. M.

“…Immuno-oncology is a rapidly developing field in medicine. Drug combination therapies have already been studied in many clinical trials of different types of…”
Get full text

The role of digital mammography, scintimammography with 99m Tc-methoxyisobutylisonitrile (MIBI) and ultrasound in the diagnosis of multicentric breast cancer by Chernaya, A. V., Krzhivitskiy, P. I., Busko, E. A., Krivorotko, P. V., Artemyeva, A. S., Popova, N. S., Danilov, V. V., Semiglazov, V. F., Novikov, S. N., Kanaev, S. V.

“…Background. The development of effective methods for diagnosing multicentric breast cancer patients (BC) is of great clinical importance, because it determines…”
Get full text

Biopsychosocial approach in the rehabilitation of patients with operable breast cancer by Kluge, V. A., Semiglazova, T. Yu, Krivorotko, P. V., Melnikova, E. V., Semiglazov, V. V., Kondrateva, K. O., Nazarova, S. G., Tynkasova, M. A., Kasparov, B. S., Adhamov, B. M., Pesotsky, R. S., Zernov, K. Yu, Kovlen, D. V., Semiglazov, V. F., Belyaev, A. V.

“…The relevance: more than 60% of cases are due to early breast cancer (EBC). Priority is the treatment of patients with early breast cancer, provided that the…”
Get full text

Immediate breast reconstruction using titanised mesh by Krivorotko, P. V., Pesotskyy, R. S., Zernov, K. Yu, Bessonov, A. A., Zhiltsova, E. K., Komyakhov, A. V., Tabagua, T. T., Nikolaev, K. S., Rychagov, K. Yu, Ivanov, V. G., Gigolaeva, L. P., Ivanova, O. A., Dashyan, G. A., Semiglazov, V. V., Emelyanov, A. S., Yerechshenko, S. S., Shishova, A. S., Munaeva, E. T., Aseeva, Z. A., Semiglazov, V. F.

“…Additional covering of the lower pole with allomaterial or its synthetic analogues during immediate breast reconstruction is being performed at the N. N…”
Get full text

Future prospects for breast cancer immunotherapy by V. F. Semiglazov, A. I. Tseluiko, R. V. Donskikh, P. V. Krivorotko, G. A. Dashyan, V. V. Semiglazov, A. V. Komyakhov

“…Immunotherapy has already become an important component of the standard treatment of patients with advanced cancer. Most treatment methods include monoclonal…”
Get full text